Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France

Antimicrob Agents Chemother. 2011 May;55(5):2420-3. doi: 10.1128/AAC.01452-10. Epub 2011 Feb 22.

Abstract

Seventeen Klebsiella pneumoniae isolates producing the OXA-48 carbapenemase, obtained from 10 patients hospitalized from April to June 2010, mostly in the medical intensive care unit of the Villeneuve-Saint-Georges Hospital in a suburb of Paris, France, were analyzed. Seven patients were infected, of whom five were treated at least with a carbapenem, and five patients died. Molecular analysis showed that the isolates belonged to a single clone that harbored a 70-kb plasmid carrying the blaOXA-48 gene and coproduced CTX-M-15 and TEM-1 β-lactamases. This is the first reported outbreak of OXA-48-producing K. pneumoniae isolates in France.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbapenems / therapeutic use*
  • Drug Resistance, Multiple, Bacterial / genetics
  • France
  • Humans
  • Klebsiella Infections / drug therapy
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / enzymology*
  • Klebsiella pneumoniae / pathogenicity
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • Carbapenems
  • beta-Lactamases
  • oxacillinase